Clinical Trial Update: A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating azacitidine in patients with intermediate/high-risk myelodysplastic syndromes and AML with myelodysplasia-related changes (AML-MRC) is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Shandong Provincial Hospital | Conditions: Myelodysplastic Syndromes,Acute Myeloid Leukemia | Phase 3 | Status: UNKNOWN